Target intelligence / Profile preview

Non-specific biomolecules (DNA, proteins, and lipids) (ROS/LOPs)

Target
ROS/LOPs
Molecular classification
Other, Macromolecules
01

Overview

Non-specific biomolecules via ROS/LOPs refers to the broad array of cellular components, including genomic DNA, functional proteins, and membrane lipids, that serve as substrates for oxidative modification by Reactive Oxygen Species (ROS) and Lipid Oxidation Products (LOPs) [Halliwell & Gutteridge, 2015]. This interaction is characterized by a lack of specificity, where highly reactive intermediates like hydroxyl radicals or lipid peroxyl radicals cause irreversible structural damage, such as DNA strand breaks, protein carbonylation, and lipid peroxidation [NIH, 2023]. In oncology, this mechanism is intentionally triggered by therapies like radiation, photodynamic therapy, and certain chemotherapeutic agents to induce cell death in malignant tissues [PubMed, 2021]. Additionally, in the context of medical ozone therapy, the generation of LOPs acts as a transient oxidative stressor that modulates various biological pathways by reacting with these biomolecules [Bocci, 2011]. However, in chronic conditions like neurodegeneration and cardiovascular disease, the uncontrolled oxidation of these biomolecules drives disease progression and tissue degradation [StatPearls, 2023]. From a drug development perspective, targeting these molecules presents a significant challenge due to the difficulty in achieving site-specific oxidation without causing systemic toxicity [PubMed, 2020].

Other names
Cellular macromoleculesOxidative stress substratesROS/LOP targetsMacromolecular targets of oxidative stress
02

Mechanism of action

Induction of non-specific oxidative damage to cellular macromolecules (DNA, proteins, and lipids) through the generation of reactive oxygen species (ROS) and lipid oxidation products (LOPs) [Halliwell & Gutteridge, 2015; Bocci, 2011].

03

Biological functions

Cell deathApoptosisSignal transductionRedox signalingCellular homeostasis
04

Disease associations

CancerNeurodegenerative diseaseInflammationCardiovascular diseaseAging
05

Safety considerations

Non-specific systemic toxicityPotential for secondary mutagenesisNarrow therapeutic indexInduction of systemic inflammatory response
06

Interacting drugs

Bleomycin

6 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)Protein carbonyl content4-Hydroxynonenal (4-HNE)

Beyond the preview

Go deeper on Non-specific biomolecules (DNA, proteins, and lipids) (ROS/LOPs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific biomolecules (DNA, proteins, and lipids) (ROS/LOPs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call